Position in AKAN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,226
+$3,656 QoQ
Shares Held
600
+35.1% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 4 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AKAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Integrated Wealth Concepts LLC holds $11,152,228 across 54 Drug Manufacturers - Specialty & Generic names. AKAN ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
18,709 | $2,075,576 | |
| 2 | VTRS |
Viatris Inc
|
93,878 | $1,490,782 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,145 | $1,372,758 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,252 | $1,220,201 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
43,764 | $1,110,292 | |
| 6 | ZTS |
Zoetis Inc.
|
8,044 | $578,041 | |
| 7 | DERM |
Journey Medical Corp
|
78,928 | $558,810 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,026 | $475,200 |
All Filings in AKAN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,226 | 600 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $4,570 | 10,000 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||